Navigation Links
QRxPharma Announces Strategic Alliance with Liaoning Nuokang Medicines Co Ltd for the Development of Venomics Assets
Date:9/24/2009

SYDNEY, Australia and BEDMINSTER, N.J., Sept. 24 /PRNewswire/ -- QRxPharma Limited (ASX: QRX and Pink Sheets: QRXPY), announced today a strategic alliance with Liaoning Nuokang Medicines Co. Ltd. ("Nuokang"), a Chinese biopharmaceutical company based in Shenyang, China, to develop and commercialise QRxPharma's venomics assets for the Chinese market. The strategic alliance involves Nuokang investing US$5.0 million for a controlling interest in a Hong Kong company that holds a license over two of QRxPharma's lead haemostasis product candidates: Textilinin, an antifibrinolytic agent, and Haempatch(TM), a potent pro-coagulant.

The transaction is expected to be completed by mid October 2009. On completion, a minority interest in the Hong Kong company will be held by Venomics Pty Ltd, which is a majority-owned subsidiary of QRxPharma and holds all of the venomics assets of QRxPharma. An affiliated company of Nuokang has also subscribed to a 10% interest in Venomics Pty Limited.

"We are very pleased to announce the strategic alliance of QRxPharma's venomics program with a leading Chinese biopharmaceutical company that has extensive experience in the development, manufacture and sale of therapeutics derived from snake venoms," said Dr. John Holaday, Managing Director and Chief Executive Officer, QRxPharma. "Blood loss in surgery and trauma is a significantly under-served market opportunity, and Nuokang's capabilities and resources will ensure that Textilinin and Haempatch(TM) progress quickly to the clinic."

Dr. Holaday further said that he was particularly pleased to have concluded this deal:

"This strategic alliance provides a great opportunity to extract value for QRxPharma shareholders from the venomics assets without diverting management's attention away from QRxPharma's main prospect with its Dual Opioid(TM) development programme in the area of pain management".<
'/>"/>

SOURCE QRxPharma Limited
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2 3 4

Related medicine news :

1. QRxPharma Expands Management Team with the Addition of Dr. Jesus Soriano as Executive Vice President
2. QRxPharma Begins Trading on the International OTCQX
3. QRxPharma Initiates Second Phase III Clinical Trial for its Dual Opioid Pain Therapy
4. I-Therapeutix, Inc. Announces Company Name Change
5. President Clinton Hosts Special Session on Northern Ireland; Announces New Commitments Focused on Harnessing Innovation for Development
6. Caraco Pharmaceutical Laboratories, Ltd. Announces Resignation of Georges Ugeux from Board of Directors
7. US Farms, Inc. Announces Broker Network Agreement With Sunshine Specialties for Aloe365 Products
8. ReBuilder Medical Technologies, Inc. Announces Medicare Billing Ability for its ReBuilder Product
9. Cardiogenesis Announces Successful Symposium at the Transcatheter Cardiovascular Therapeutics (TCT) Meeting
10. Strategic Information Group Announces QAD Enterprise Validation Partnership
11. Natural Alternatives International, Inc. Announces Fiscal 2009 Q4 and Full Year Results
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:8/27/2014)... StartX , a nonprofit technology accelerator ... a pioneering institute driving biotechnology innovation at the University ... laboratory customized for the needs of early stage medical ... lab space, named “StartX-QB3 Labs,” is the first research ... Care focused on developing entrepreneurs from academia to industry. ...
(Date:8/27/2014)... August 27, 2014 For the first ... face on plastic surgery when triple-board certified, Park Avenue ... figurative clay sculptures he has created from life – ... and artistry at a unique event on September 9, ... at 23 Warren Street. The “faces” who will be ...
(Date:8/27/2014)... Humility of Mary Health Partners will offer SlimDown, ... Center in Boardman beginning Sept. 2 and at St. ... , SlimDown teaches participants to manage their weight by ... and behavior. , Classes run from 5:30 to 6:30 ... Mondays at St. Joe’s at the Mall. , The ...
(Date:8/27/2014)... 27, 2014 Two of Woodland Hills’ ... Jivraj of the Anacapa Dental Art Institute, deal with serious ... complex oral surgery. , So patients can be reluctant to ... sores left from biting their lip or gums. , “The ... by the accidental bite,” Dr. Reshad said. “This canker or ...
(Date:8/27/2014)... A recent news article in the Richmond, ... “Five tips for relieving dry skin.” Sharon Kleyne, international ... Power of Water radio show describes the article’s five ... are seldom reported but which, Kleyne believes, are equally ... is Founder of Bio Logic Aqua Research, a global ...
Breaking Medicine News(10 mins):Health News:StartX & QB3 Launch Lab for Life Science and Medical Technology Entrepreneurs 2Health News:StartX & QB3 Launch Lab for Life Science and Medical Technology Entrepreneurs 3Health News:StartX & QB3 Launch Lab for Life Science and Medical Technology Entrepreneurs 4Health News:Presenting A Remarkable Fusion of Art, Fashion and Plastic Surgery 2Health News:Humility of Mary Health Partners Offers SlimDown Classes 2Health News:Two of Ventura’s Best Cosmetic Dentists Offer 5 Tips for Dealing with Frequent Tongue or Lip Biting 2Health News:Two of Ventura’s Best Cosmetic Dentists Offer 5 Tips for Dealing with Frequent Tongue or Lip Biting 3Health News:Two of Ventura’s Best Cosmetic Dentists Offer 5 Tips for Dealing with Frequent Tongue or Lip Biting 4Health News:Two of Ventura’s Best Cosmetic Dentists Offer 5 Tips for Dealing with Frequent Tongue or Lip Biting 5Health News:Water Advocate Sharon Kleyne Reports New Discoveries for Relief of Dry Dehydrated Skin 2Health News:Water Advocate Sharon Kleyne Reports New Discoveries for Relief of Dry Dehydrated Skin 3
... as a potential heart disease therapy, raising high-density lipoprotein ... protein may not be effective, a new study suggests. ... Center on Aging (USDA HNRCA) at Tufts University ... between low plasma cholesterol ester transfer protein (CETP) activity ...
... ... Intelligence Agency has requested documents from an investigative journalist, even though the writer had ... , ... 15, 2009 -- In a bizarre about-face, the secretive Central Intelligence Agency has requested ...
... ... ... -- The popularity and hype surrounding buttock augmentation and other large-volume body enhancing injections ... deadly trend, cautions the Physicians Coalition for Injectable Safety . Permanent fillers ...
... for inflammatory marker may spot people in need of ... -- People with normal levels of LDL (bad) cholesterol ... inflammation in order to identify those who may benefit ... of heart attack, stroke and death, say U.S. researchers. ...
... , , PALM ... Inc. (Pink Sheets: CTYX) announced today that it has ... Sheets (Pink Sheets Current Information). The higher move ... Information available. http://www.pinksheets.com/content/doc/ps/Disclosure/Guidelines/2.pdf , Connectyx President Ronn ...
... Dec. 15 At a time when Americans spend over ... Dr. Raymond Hall is theorizing a painful connection between conventional ... Pillo1 ( www.pillo1.com ) to address the problem. A ... Sleep Disorders Center showed that Pillo1 re-educates the body to ...
Cached Medicine News:Health News:Low cholesterol transfer protein activity associated with heart disease risk 2Health News:CIA Requests its Own Documents from Author 2Health News:CIA Requests its Own Documents from Author 3Health News:Physicians Coalition for Injectable Safety Warns Buttock-Boosting Injections Risky and Deadly 2Health News:Physicians Coalition for Injectable Safety Warns Buttock-Boosting Injections Risky and Deadly 3Health News:Physicians Coalition for Injectable Safety Warns Buttock-Boosting Injections Risky and Deadly 4Health News:Normal Cholesterol Doesn't Guarantee Healthy Heart 2Health News:Connectyx Attains 'Current Listing' Status on Pink Sheets Exchange 2Health News:Connectyx Attains 'Current Listing' Status on Pink Sheets Exchange 3Health News:Sleep Study Shows Pillo1 Re-Educates Body to Naturally Move Into Optimal Sleep Position and Increases REM Sleep by 21.3% 2
(Date:8/26/2014)... Aug. 26, 2014  Ethicon* is introducing three new ... unique challenges of bariatric procedures such as sleeve gastrectomy ... today at the 19th World Congress of International Federation ... 2014), where Ethicon is featuring the new ECHELON FLEX ... ® G2 Articulating Tissue Sealer alongside the HARMONIC ...
(Date:8/26/2014)... 26, 2014 SynCardia Systems, Inc., manufacturer of ... the Inc. 5000 named by the business magazine ... FDA, Health Canada and CE approved Total Artificial Heart, ... donor heart transplant," says Michael P. Garippa , ... of care for patients dying from end-stage biventricular heart ...
(Date:8/26/2014)... , Aug. 26, 2014    Practice Fusion ... (EHR) platform , today announced the addition to its ... company,s chief commercial officer and Joe Priest ... the heels of Practice Fusion,s recent hire of Robert ... further expansion of the company,s executive bench. With the ...
Breaking Medicine Technology:Ethicon Expands Bariatric Surgery Portfolio; Unveils "Evidence Corner" At IFSO To Address Obesity And Metabolic Diseases 2Ethicon Expands Bariatric Surgery Portfolio; Unveils "Evidence Corner" At IFSO To Address Obesity And Metabolic Diseases 3Ethicon Expands Bariatric Surgery Portfolio; Unveils "Evidence Corner" At IFSO To Address Obesity And Metabolic Diseases 4Ethicon Expands Bariatric Surgery Portfolio; Unveils "Evidence Corner" At IFSO To Address Obesity And Metabolic Diseases 5Ethicon Expands Bariatric Surgery Portfolio; Unveils "Evidence Corner" At IFSO To Address Obesity And Metabolic Diseases 6Inc. Magazine Ranks SynCardia Systems in Top 3rd in its 2014 Inc. 5000 List 2Practice Fusion Further Expands Executive Team with Chief Commercial Officer and VP of Pharmaceutical Partnerships Hires 2Practice Fusion Further Expands Executive Team with Chief Commercial Officer and VP of Pharmaceutical Partnerships Hires 3
... Sysmex, a global leader in medical diagnostic testing ... organizational changes that further position the company,s North ... John Kershaw, President & CEO, Sysmex America, Inc. ... Executive Vice President, Marketing, Business Development and Medical/Scientific ...
... 2010 HeartSine Technologies received the Outstanding ... Awards ceremony, November 25th, in Belfast, Northern Ireland. The ... contributions to Belfast and surrounding communities. The ... Group in 1997 to honor champions and ambassadors ...
Cached Medicine Technology:Sysmex America Announces Executive Promotions 2HeartSine Technologies Wins 2010 Aisling Award for Outstanding Achievement in Business 2
An immunochromatographic rapid test for the detection of Plasmodium falciparum in whole blood....
Malaria device / strip (2 line, PAN specific-pLDH)...
Malaria device / strip (3 line, P.f/P.v Ag Test-pLDH)...
High sensitive, specific one step immunochromatographic assay for human infectious disease...
Medicine Products: